Literature DB >> 21714827

Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans.

Victoria E Johnson1, William Stewart, Douglas H Smith.   

Abstract

While a history of a single traumatic brain injury (TBI) is associated with the later development of syndromes of cognitive impairment such as Alzheimer's disease, the long-term pathology evolving after single TBI is poorly understood. However, a progressive tauopathy, chronic traumatic encephalopathy, is described in selected cohorts with a history of repetitive concussive/mild head injury. Here, post-mortem brains from long-term survivors of just a single TBI (1-47 years survival; n=39) vs. uninjured, age-matched controls (n=47) were examined for neurofibrillary tangles (NFTs) and amyloid-β (Aβ) plaques using immunohistochemistry and thioflavine-S staining. Detailed maps of findings permitted classification of pathology using semiquantitative scoring systems. NFTs were exceptionally rare in young, uninjured controls, yet were abundant and widely distributed in approximately one-third of TBI cases. In addition, Aβ-plaques were found in a greater density following TBI vs. controls. Moreover, thioflavine-S staining revealed that while all plaque-positive control cases displayed predominantly diffuse plaques, 64% of plaque-positive TBI cases displayed predominantly thioflavine-S-positive plaques or a mixed thioflavine-S-positive/diffuse pattern. These data demonstrate that widespread NFT and Aβ plaque pathologies are present in up to a third of patients following survival of a year or more from a single TBI. This suggests that a single TBI induces long-term neuropathological changes akin to those found in neurodegenerative disease.
© 2011 The Authors. Brain Pathology © 2011 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714827      PMCID: PMC3979351          DOI: 10.1111/j.1750-3639.2011.00513.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  42 in total

1.  An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  R Guntern; C Bouras; P R Hof; P G Vallet
Journal:  Experientia       Date:  1992-01-15

2.  Alzheimer's disease after remote head injury: an incidence study.

Authors:  P W Schofield; M Tang; K Marder; K Bell; G Dooneief; M Chun; M Sano; Y Stern; R Mayeux
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury.

Authors:  S M Gentleman; B D Greenberg; M J Savage; M Noori; S J Newman; G W Roberts; W S Griffin; D I Graham
Journal:  Neuroreport       Date:  1997-04-14       Impact factor: 1.837

4.  Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

Authors:  E S O'Meara; W A Kukull; L Sheppard; J D Bowen; W C McCormick; L Teri; M Pfanschmidt; J D Thompson; G D Schellenberg; E B Larson
Journal:  Am J Epidemiol       Date:  1997-09-01       Impact factor: 4.897

5.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

Authors:  G W Roberts; S M Gentleman; A Lynch; L Murray; M Landon; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

6.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Head injury and the risk of Alzheimer's disease: a case control study.

Authors:  E Salib; V Hillier
Journal:  Int J Geriatr Psychiatry       Date:  1997-03       Impact factor: 3.485

8.  Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

Authors:  J C Troncoso; L J Martin; G Dal Forno; C H Kawas
Journal:  Neurobiol Aging       Date:  1996 May-Jun       Impact factor: 4.673

9.  Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases.

Authors:  P R Hof; C Bouras; L Buée; A Delacourte; D P Perl; J H Morrison
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Distribution of beta-amyloid protein in the brain following severe head injury.

Authors:  D I Graham; S M Gentleman; A Lynch; G W Roberts
Journal:  Neuropathol Appl Neurobiol       Date:  1995-02       Impact factor: 8.090

View more
  234 in total

Review 1.  Dementia resulting from traumatic brain injury: what is the pathology?

Authors:  Sharon Shively; Ann I Scher; Daniel P Perl; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2012-10

2.  Traumatic brain injury history is associated with earlier age of onset of frontotemporal dementia.

Authors:  Christian LoBue; Kristin Wilmoth; C Munro Cullum; Heidi C Rossetti; Laura H Lacritz; Linda S Hynan; John Hart; Kyle B Womack
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-09-10       Impact factor: 10.154

Review 3.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

4.  Military risk factors for Alzheimer's disease.

Authors:  Michael W Weiner; Karl E Friedl; Anthony Pacifico; Julie C Chapman; Michael S Jaffee; Deborah M Little; Geoffrey T Manley; Ann McKee; Ronald C Petersen; Roger K Pitman; Kristine Yaffe; Henrik Zetterberg; Robert Obana; Lisa J Bain; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2013-07       Impact factor: 21.566

5.  Neuromechanics and Pathophysiology of Diffuse Axonal Injury in Concussion.

Authors:  Douglas H Smith
Journal:  Bridge (Wash D C)       Date:  2016-04-12

6.  Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

Authors:  Li-Ming Wang; Qi Wu; Ryan A Kirk; Kevin P Horn; Ahmed H Ebada Salem; John M Hoffman; Jeffrey T Yap; Joshua A Sonnen; Rheal A Towner; Fernando A Bozza; Rosana S Rodrigues; Kathryn A Morton
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain.

Authors:  Giridhar Murlidharan; Andrew Crowther; Rebecca A Reardon; Juan Song; Aravind Asokan
Journal:  JCI Insight       Date:  2016-09-08

Review 8.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

9.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

Review 10.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.